Skip to main content
. 2001 May;69(5):3067–3072. doi: 10.1128/IAI.69.5.3067-3072.2001

FIG. 2.

FIG. 2

Survival of B. pertussis in complement. BP338 and BPM2041 were incubated with 10% human serum for 15 (P < 0.0038) or 120 (P < 0.0012) min. Percent survival is calculated relative to a non-killing heat-inactivated serum control. The results are the average and standard error of four separate trials. BPM2041 is the BrkA mutant; BP338 is the wild type.